INTERNATIONAL PATENT: TEIJIN PHARMA LIMITED, 帝人ファーマ株式会社 FILES APPLICATION FOR "PHARMACEUTICAL AND ANTI-GPNMB ANTIBODY FOR REMOVING DISEASE-ASSOCIATED CELLS"

GENEVA, March 10 -- TEIJIN PHARMA LIMITED (2-1, Kasumigaseki 3-chome, Chiyoda-ku, Tokyo1000013), 帝人ファーマ株式会社 (東京都千代田区霞が関三丁目２番１号) filed a patent application (PCT/JP2024/030861) for "PHARMACEUTICAL AND ANTI-gpNMB ANTIBODY FOR REMOVING DISEASE-ASSOCIATED CELLS" on Aug 29, 2024. With publication no. WO/2025/047838, the details related to the patent application was published on Mar 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization ...